no statement of use filed
on 11 Sep 2023
Last Applicant/ Owned by
80 W. Lancaster Avenue
Devon
PA
19333
Serial Number
88291596 filed on 06th Feb 2019
Registration Number
N/A
Correspondent Address
Sarah Anne Keefe
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
The color(s) purple, yellow, orange and red is/are claimed as a feature of the mark. Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitivRead More
Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders and all of the foregoing solely derived from manufactured synthetic cannabidiol and which do not contain delta-9 tetrahydrocannabinol (THC)
No 88291596
No Service/Collective Mark
No 103015.227.1
No
No
No
No
No
No
No
No
01.15.18 -
More than one drop including teardrops or raindrops
26.11.14 -
Three or more rectangles
26.11.16 -
Rectangles touching or intersecting
26.11.21 -
Rectangles that are completely or partially shaded
The mark consists of the word "ZYGEL" in purple stylized text to the left of an arrangement of vertical and horizontal, yellow and orange rectangles with rounded ends featuring three purple teardrop shapes and two red teardrop shapes within a grid pattern created by the rectangles.
| Status Date | Action Taken |
|---|---|
| 11th Sep 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 11th Sep 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 23rd Feb 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Feb 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 22nd Feb 2023 | SOU EXTENSION 5 GRANTED |
| 06th Feb 2023 | SOU TEAS EXTENSION RECEIVED |
| 06th Feb 2023 | SOU EXTENSION 5 FILED |
| 28th Jun 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 24th Jun 2022 | SOU TEAS EXTENSION RECEIVED |
| 24th Jun 2022 | SOU EXTENSION 4 FILED |
